PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-185.65%
Negative net income growth while MCHP stands at 14.85%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
10.42%
D&A growth well above MCHP's 16.10%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-133.33%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
142.46%
Slight usage while MCHP is negative at -67.96%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
79.63%
Some inventory rise while MCHP is negative at -909.22%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
123.45%
Some yoy usage while MCHP is negative at -42.35%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
138.10%
Well above MCHP's 6.78%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
392.44%
Some CFO growth while MCHP is negative at -8.39%. John Neff would note a short-term liquidity lead over the competitor.
62.00%
Some CapEx rise while MCHP is negative at -50.71%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-80.35%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
16.62%
Liquidation growth of 16.62% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
60.91%
We have mild expansions while MCHP is negative at -50.71%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
7.14%
Lower share issuance yoy vs. MCHP's 595.00%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
-2057.14%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.